Referral of Patients With Biological Abnormalities to an Emergency Department

NCT07405996 | Not Yet Recruiting

• 1 other identifier: 2025-06-Obs-CHRMT
• Study Type: observational
• Target: 5,000
• Locations: 1 country
• Sites: 1

Brief Summary

Biological testing is an essential part of general medical practice and plays a role in 60% to 70% of diagnoses. 68.5% of prescriptions are written by general practitioners, and one in seven general medical consultations ends with a prescription for biological testing. The study of patient trajectories is a recent emerging topic in the literature, encompassing general concepts. The angle most often taken is medico-economic and focused on specific chronic conditions such as diabetes, cancer, or cardiovascular disease. To our knowledge, there are a number of referrals to emergency departments by general practitioners for patients with biological abnormalities. However, to our knowledge, no study to date has attempted to quantify these specific referrals.

Conditions

Biological Abnormality; Emergency Department Visit; General Practitioner

Outcome Measures

Primary Outcomes (1)

• Type of biological abnormality and severity level

  The primary evaluation criterion is the type of biological abnormality sent to the emergency department and its severity (depth or elevation).

  Immediately upon admission to the emergency room

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Any patient presenting at an emergency department participating in the IOA (nurse coordinating reception) system with the reason for referral "Abnormal laboratory results.

You may qualify if:

• Any patient presenting at an emergency department participating in the IOA (nurse coordinating reception) system with the reason for referral "Abnormal laboratory results.

You may not qualify if:

• minor patients (\<18 years old)
• expression of the patient's opposition to the collection of data relating to their hospital stay.

Sponsors & Collaborators

• Centre Hospitalier Régional Metz-Thionville: lead

Study Sites (1)

CHR Metz-Thionville

Metz, France, 57085, France

Location

Central Study Contacts

Andreia CARVALHO DE FREITAS

CONTACT

0033387553323; projet-recherche-clinique@chr-metz-thionville.fr

Laure ABENSUR VUILLAUME

CONTACT

laure.abensur-vuillaume@chr-metz-thionville.fr

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 27, 2026
• First Posted: February 12, 2026
• Study Start: February 1, 2026
• Primary Completion (Estimated): February 1, 2027
• Study Completion (Estimated): February 1, 2027
• Last Updated: February 12, 2026

Record last verified: 2026-01

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)